Detection of necrotic malignant tissue and associated therapy
AssigneeTechniclone, Inc.
InventorsAlan L. Epstein, Clive R. Taylor
Life of this patent
Estimating the term…
Loading patent…
AssigneeTechniclone, Inc.
InventorsAlan L. Epstein, Clive R. Taylor
Estimating the term…
Disclosed are methods for identifying the presence of a tumor in a mammal, comprising the steps of obtaining an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled with a label capable of being imaged; administering the antibody to the mammal, thereby permitting the antibody to bind preferentially to necrotic tissue; and imaging the binding of the antibody to the necrotic tissue, wherein a localized concentration of said antibody is indicative of the presence of a tumor. The antibodies used in these methods are preferably monoclonal antibodies, are also preferably specific for one or more nuclear proteins, and are also preferably labeled with one or more radionuclides. Also disclosed are antibodies for use with the foregoing methods.
A method for identifying the presence of a tumor in a mammal, comprising the steps of:
Dependencies are inferred from the claim text.